To analyze the recovery of retinal lines using swept-source optical coherence tomography after inverted internal limiting membrane flap technique to treat full-thickness macular hole, and the relationship between best-corrected visual acuity and retinal line repair.
Thirty-eight eyes were evaluated for recovery of the external limiting membrane, photoreceptor inner segment/outer segment junction line, and cone outer segment tips (COST) line. Correlation between the recovery of retinal lines and best-corrected visual acuity improvement was analyzed 6 months after surgery.
The closure rate of full-thickness macular hole was 97%. The best recovery rates were associated with external limiting membrane line recovery (25 eyes, 65.8%), followed by inner segment/outer segment line recovery (22 eyes, 57.9%), and less frequently, COST line recovery (9 eyes, 23.7%); moreover, recovery of the COST line was apparent only in eyes with recovered external limiting membrane and inner segment/outer segment lines. Mean postoperative visual acuity in the COST line recovery group (COST+) was 20/42 (0.48, 0.33 logarithm of the minimum angle of resolution), compared with 20/95 (0.21, 0.68 logarithm of the minimum angle of resolution) without COST line recovery (COST−). Final visual acuity was significantly better in the COST+ group compared with the COST− group (P = 0.002).
Cone outer segment tips line recovery is correlated with best-corrected visual acuity improvement for eyes treated with inverted internal limiting membrane flap technique for full-thickness macular hole.
To analyze the recovery of retinal lines using swept-source optical coherence tomography, as well as changes in best-corrected visual acuity, after inverted internal limiting membrane flap technique for full-thickness macular hole. Recovery of the cone outer segment tips line was associated with significant best-corrected visual acuity improvement.
*Clinical Unit of Ophthalmology and Ocular Oncology, University Hospital, Kraków, Poland; and
†Department of Ophthalmology, Jagiellonian University Medical College, Kraków, Poland.
Reprint requests: Krzysztof Morawski, PhD, Clinical Unit of Ophthalmology and Ocular Oncology, University Hospital, 38 Kopernika St., 31-501, Kraków, Poland; e-mail: email@example.com
None of the authors has any financial/conflicting interests to disclose.
The authors declare no affiliations with or involvement in any organization or entity with any financial interest in relation to this article. We have read and understood British Medical Journal (BMJ) policy on declaration of interests and declare that we have no competing interests.